| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 416.20B | 369.44B | 370.51B | 417.55B | 401.14B |
| Gross Profit | 127.80B | 111.58B | 102.47B | 127.52B | 120.08B |
| EBITDA | 124.39B | 100.20B | 94.42B | 127.28B | 112.48B |
| Net Income | 63.71B | 33.70B | 31.49B | 52.19B | 41.23B |
Balance Sheet | |||||
| Total Assets | 960.42B | 1.08T | 1.13T | 857.51B | 664.33B |
| Cash, Cash Equivalents and Short-Term Investments | 295.68B | 390.66B | 443.58B | 302.42B | 185.59B |
| Total Debt | 192.54B | 343.06B | 385.05B | 270.20B | 175.03B |
| Total Liabilities | 403.01B | 584.38B | 628.20B | 431.90B | 293.61B |
| Stockholders Equity | 550.07B | 490.50B | 494.94B | 419.24B | 364.57B |
Cash Flow | |||||
| Free Cash Flow | 289.00M | -78.59B | 59.77B | 22.52B | 42.17B |
| Operating Cash Flow | 106.41B | 118.89B | 145.23B | 125.75B | 108.37B |
| Investing Cash Flow | -52.42B | -164.18B | -77.27B | -104.02B | -67.72B |
| Financing Cash Flow | -157.51B | -7.11B | 67.53B | 92.58B | 13.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥768.45B | 25.93 | ― | 2.18% | 3.12% | 2.74% | |
74 Outperform | ¥1.28T | 33.22 | 15.75% | 1.08% | 18.84% | 42.10% | |
69 Neutral | ¥500.52B | 14.64 | 6.30% | 2.16% | 4.78% | ― | |
68 Neutral | ¥438.96B | 35.25 | 5.63% | 2.35% | -3.24% | -36.64% | |
66 Neutral | ¥5.93T | 92.50 | 7.72% | 0.40% | 12.66% | 89.12% | |
64 Neutral | ¥7.30T | 38.22 | ― | 1.41% | 13.61% | 17.01% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |